Craig H Moskowitz Selected Research

Vincristine (Oncovin)

1/2024	Matched control analysis suggests R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared to R-CHOP.
1/2023	Prognostic Value of 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen.
12/2015	Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era.
4/2011	Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma.
4/2010	Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.
9/2005	Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999.
4/2005	R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Craig H Moskowitz Research Topics

Disease

49	Hodgkin Disease (Hodgkin's Disease) 03/2024 - 03/2004
27	Lymphoma (Lymphomas) 09/2023 - 09/2002
25	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 09/2003
16	Neoplasms (Cancer) 01/2024 - 03/2004
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 11/2004
8	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 09/2005
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020 - 09/2009
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2023 - 11/2004
3	Nausea 12/2021 - 03/2015
3	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 11/2016
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2015 - 07/2006
3	T-Cell Lymphoma (Lymphoma, T Cell) 12/2013 - 11/2007
2	Hypertension (High Blood Pressure) 01/2022 - 08/2017
2	Exanthema (Rash) 01/2022 - 01/2019
2	Anemia 01/2019 - 08/2017
2	Disease Progression 10/2018 - 11/2016
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2009 - 07/2006
1	Diarrhea 01/2022
1	Hyperglycemia 01/2022
1	Dermatitis 01/2022
1	Pruritus (Itching) 01/2022
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2021
1	Bites and Stings (Sting) 12/2019
1	Second Primary Neoplasms (Neoplasms, Second) 10/2019
1	Thyroiditis 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Colitis 01/2019
1	Multiple Myeloma 08/2017
1	Hyperhidrosis 08/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2016
1	Leukemia 10/2016

Drug/Important Bio-Agent (IBA)

17	Brentuximab VedotinIBA 03/2024 - 06/2012
16	Rituximab (Mabthera)FDA Link 01/2024 - 09/2002
11	pembrolizumabIBA 01/2023 - 11/2016
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 04/2005
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 04/2005
7	Vincristine (Oncovin)FDA LinkGeneric 01/2024 - 04/2005
6	Prednisone (Sone)FDA LinkGeneric 01/2024 - 04/2005
5	Etoposide (VP 16)FDA LinkGeneric 01/2024 - 05/2013
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2023 - 01/2014
4	IceIBA 01/2024 - 05/2004
4	Carboplatin (JM8)FDA LinkGeneric 01/2024 - 07/2013
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2010
4	NivolumabIBA 12/2021 - 01/2018
3	Ifosfamide FDA LinkGeneric 01/2024 - 07/2013
3	PlatinumIBA 01/2022 - 07/2013
3	ibrutinibIBA 01/2022 - 01/2017
3	Immunoconjugates (Immunoconjugate)IBA 12/2019 - 02/2015
3	Monoclonal AntibodiesIBA 01/2018 - 07/2013
3	Bendamustine Hydrochloride FDA Link 08/2017 - 02/2013
3	Methotrexate (Mexate)FDA LinkGeneric 02/2015 - 11/2003
3	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2013 - 11/2003
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 01/2017
2	Gemcitabine FDA Link 10/2021 - 02/2013
2	Busulfan (Busulfex)FDA Link 01/2017 - 02/2015
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2017 - 02/2015
2	Anaplastic Lymphoma KinaseIBA 12/2013 - 07/2006
2	Bortezomib (Velcade)FDA Link 04/2011 - 11/2004
2	Reduced Folate Carrier ProteinIBA 09/2009 - 11/2007
2	10-propargyl-10-deazaaminopterin FDA Link 09/2009 - 11/2007
1	Lenalidomide (CC 5013)FDA Link 08/2023
1	NVP-BKM120IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021
1	liposomal doxorubicin (Doxil)FDA Link 10/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2021
1	Chimeric Antigen ReceptorsIBA 12/2019
1	Immune Checkpoint InhibitorsIBA 10/2019
1	EnzymesIBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	Heme (Haem)IBA 12/2018
1	ParaffinIBA 12/2018
1	Formaldehyde (Formol)FDA Link 12/2018
1	RNA (Ribonucleic Acid)IBA 12/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2018
1	Dacarbazine (DIC)FDA LinkGeneric 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2017
1	veliparibIBA 08/2017
1	Alkylating AgentsIBA 08/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 01/2017
1	LigandsIBA 11/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2016

Therapy/Procedure

41	Therapeutics 08/2023 - 09/2002
34	Drug Therapy (Chemotherapy) 03/2024 - 09/2003
27	Stem Cell Transplantation 03/2024 - 09/2002
11	Transplantation 01/2019 - 11/2003
9	Radiotherapy 01/2021 - 04/2008
7	Salvage Therapy 12/2021 - 02/2015
6	Autologous Transplantation 01/2019 - 07/2006
5	Cell Transplantation 09/2023 - 05/2013
5	Chemoradiotherapy 10/2018 - 03/2004
3	Immunotherapy 01/2021 - 01/2019
2	Aftercare (After-Treatment) 10/2019 - 05/2015
2	Hematopoietic Stem Cell Transplantation 12/2018 - 08/2010
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2017
1	Lymphatic Irradiation 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 10/2016